Ovagen Peptide

Hepatic bioregulatory tripeptide (Glu-Asp-Leu). Researched for liver function normalization and lipid metabolism regulation in aging models.

Coming Soon

This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.

Quick Facts

SKUOVA-001
SequenceGlu-Asp-Leu
Purity≥98%
Physical FormLyophilized Powder
StorageStore at -20°C

What is Ovagen (Glu-Asp-Leu)?

Hepatic tripeptide normalizing liver parenchymal cell function. Research shows improved lipid metabolism (reduced hepatic steatosis), enhanced albumin synthesis, and normalized bilirubin conjugation in aging liver models.

Frequently Asked Questions

Ovagen vs Livagen — both hepatic?

Both target liver but differently. Livagen (KEDA) works via chromatin decondensation (epigenetic). Ovagen (EDL) normalizes hepatocyte metabolic function (lipid metabolism, albumin synthesis). They are complementary.

For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.